Effects of dexmedetomidine on mortality rate and inflammatory responses to endotoxin-induced shock in rats
- 1 June 2004
- journal article
- research article
- Published by Ovid Technologies (Wolters Kluwer Health) in Critical Care Medicine
- Vol. 32 (6), 1322-1326
- https://doi.org/10.1097/01.ccm.0000128579.84228.2a
Abstract
The aim of this study was to document the effects of a new sedative agent, dexmedetomidine, on the mortality rate and inflammatory responses to endotoxin-induced shock in rats. Randomized laboratory study. University experimental laboratory. Fifty-seven male rats. The animals were randomly assigned to one of four groups. The endotoxemic group (n = 16) received intravenous Escherichia coli endotoxin (15 mg/kg over 2 mins). The saline control group (n = 10) was given saline alone. The dexmedetomidine alone group (n = 15) was treated identically to the control group but also received dexmedetomidine (infusion at 5 μg·kg−1·hr−1) immediately after the injection of 0.9% saline. The dexmedetomidine-endotoxin group (n = 16) was treated identically to the endotoxemic group with the additional administration of dexmedetomidine (infusion at 5 μg·kg−1·hr−1) immediately after endotoxin injection. Hemodynamics and arterial blood gases were recorded and plasma cytokine concentrations measured during the observation. The mortality rate was assessed up to 8 hrs after endotoxin or saline injection. In addition, microscopic findings of lung tissue for each group were obtained at necropsy. Mortality rates 8 hrs after endotoxin injection were 94%, 10%, 0%, and 44% for the endotoxemic, saline control, dexmedetomidine alone, and dexmedetomidine-endotoxin groups, respectively. Hypotension and increases in plasma cytokine (tumor necrosis factor-α and interleukin-6) concentrations and infiltration of neutrophils in the airspace or vessel walls of the lungs were less in the dexme-detomidine-endotoxin group than in the endotoxemic group. Dexmedetomidine reduced mortality rate and had an inhibitory effect on inflammatory response during endotoxemia. These findings suggest that dexmedetomidine administration may inhibit the inflammatory response.Keywords
This publication has 16 references indexed in Scilit:
- Preliminary UK experience of dexmedetomidine, a novel agent for postoperative sedation in the intensive care unitAnaesthesia, 1999
- Ventilatory Effects of Dexmedetomidine, Atipamezole, and Isoflurane in DogsAnesthesiology, 1992
- Staphylococcus epidermidis induces complement activation, tumor necrosis factor and interleukin-1, a shock-like state and tissue injury in rabbits without endotoxemia. Comparison to Escherichia coli.JCI Insight, 1991
- Clonidine-Induced Analgesia in Postoperative PatientsAnesthesiology, 1990
- Endotoxin and tumor necrosis factor challenges in dogs simulate the cardiovascular profile of human septic shock.The Journal of Experimental Medicine, 1989
- Tumor Necrosis Factor and Interleuktn-1 in the Serum of Children with Severe Infectious PurpuraThe New England Journal of Medicine, 1988
- Characterization of the selectivity, specificity and potency of medetomidine as an α2-adrenoceptor agonistEuropean Journal of Pharmacology, 1988
- Shock and Tissue Injury Induced by Recombinant Human CachectinScience, 1986
- Intravascular activation of complement and acute lung injury. Dependency on neutrophils and toxic oxygen metabolites.JCI Insight, 1982
- Inflammation and MediatorsInternational Journal of Dermatology, 1980